Hetero Biopharma co-hosted and participated in BioAsia 2020 for the fourth consecutive year!!
BioAsia is a celebrated global platform that enhances, enriches and encourages newer innovations, path breaking discoveries and effective solutions in the biologics industry comprising of Biotech & Biopharma companies. Bio Asia 2020 talks about “today for tomorrow”, exploring the capabilities of life sciences companies to invest in Today to thrive and create value Tomorrow.
The event witnessed high profile deliberations and discussions on hot current topics of the global life science industry by industry stalwarts including Dr. Carl H June, Mr Vas Narsimhan- Global CEO – Novartis and Ms. Kiran Mazumdar Shaw, CEO- Biocon and top executives from SUN pharma, Dr Reddy’s and Piramal healthcare.
Hetero Biopharma’s seamlessly designed booth conceptualised on the theme ‘REACH’ attracted close to 300+ participants (both domestic and international) from various verticals of health care industry viz research institutions, investors, service providers, policy makers, regulators and analysts.
This event offered a perfect platform to project the achievements of Hetero Group as a leader in ARVs and APIs and also to present rapid advances made by Hetero Biopharma in developing affordable biosimilar drugs.
The prototypes of the packs highlighting their security features was the talking point among the visitors as it effectively showcased our efforts in preventing the menace of counterfeit drugs.
The presence of Mr Murali Krishna Reddy Director- Marketing, Emerging markets had a motivating effect on Hetero Biopharma marketing team. Headed by Dr. A.V. Jayapala Reddy, AVP and Global head - Biologics Business, the Hetero Biopharma team comprising of Dr. Vikram Kumar Shetty GM - Medico marketing and Clinical affairs, Mr. Y. Ramesh Reddy - Marketing Manager, Mr. A. Vinod, Manager - Marketing, Mr. Shanker Maharaju - Manager, Mr. D. Sharath Asst. Manager- Marketing, and Mr. T. Sai Pavan Kumar - Marketing Officer, contributed to this event’s huge success.